MktsMarkets

Ionis Pharmaceuticals, Inc.
NASDAQ: IONSKey statistics
IONS News
Stories mentioning IONS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 246,091 | 203,330 | 156,719 | 452,049 | 131,612 | 226,577 | 133,814 | 225,250 |
| Cost of Goods Sold | 2,983 | 7,957 | 2,338 | 4,151 | 1,463 | 3,829 | 1,071 | 4,164 |
| Gross Profit | 243,108 | 195,374 | 154,381 | 447,898 | 130,149 | 222,748 | 132,743 | 221,086 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 150,359 | 130,186 | 96,809 | 90,622 | 76,250 | 88,079 | 61,638 | 65,113 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (117,424) | (214,459) | (160,182) | 139,816 | (146,860) | (110,821) | (148,656) | (66,091) |
| Interest Income | ||||||||
| Interest Expense | 5,160 | 4,828 | 4,212 | 4,114 | 4,108 | 4,192 | 4,161 | 4,490 |
| Other Expense | (456.00) | (16,288) | 363.00 | 102.00 | 465.00 | 302.00 | 142.00 | 610.00 |
| Pretax Income | (92,310) | (227,917) | (128,393) | 123,531 | (146,822) | (107,038) | (144,101) | (66,201) |
| Tax Provision | 218.00 | 1,477 | 213.00 | (20.00) | 116.00 | (2,689) | (3,621) | 64.00 |
| Net Income (Loss) | (92,528) | (229,394) | (128,606) | 123,551 | (146,938) | (104,349) | (140,480) | (66,265) |
| Earnings Per Share (Basic) | (0.56) | (1.41) | (0.80) | 0.78 | (0.93) | (0.66) | (0.95) | (0.45) |
| Earnings Per Share (Diluted) | (0.56) | (1.41) | (0.80) | 0.70 | (0.93) | (0.66) | (0.95) | (0.45) |
| Weighted Average Shares Outstanding (Basic) | 164,874 | 160,010 | 159,765 | 159,137 | 158,735 | 149,514 | 148,593 | 145,958 |
| Weighted Average Shares Outstanding (Diluted) | 164,874 | 160,010 | 159,765 | 182,331 | 158,735 | 149,514 | 148,593 | 145,958 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IONS
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is a stock listed on the Nasdaq Stock Market under the ticker symbol IONS. It last traded at $43.42 (Oct 26, 2026, 4:00 PM ET), up 1.1% on the day. That gives Ionis Pharmaceuticals a market capitalisation of $7.1B.
Over the past 52 weeks IONS has traded between $42.08 and $86.74.
Revenue for the quarter ended Mar 31, 2026 was $246.1M; a net loss of $92.5M. Revenue was up 87.0% from $131.6M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $246.1M | -$92.5M | -37.6% |
| Dec 31, 2025 | $203.3M | -$229.4M | -112.8% |
| Sep 30, 2025 | $156.7M | -$128.6M | -82.1% |
| Jun 30, 2025 | $452.0M | $123.6M | 27.3% |
From Ionis Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…